BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2015

Aug 7, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2015-08-05

Reporting Person: INGRAM ROBERT ALEXANDER (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-05	Non-Qualified Stock Option	$14.88	A	18750	Acquired	2025-08-05	Common Stock (18750)	Direct

Footnotes

F1: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (the "Plan").

F2: Vest 1/9 per month over nine months beginning September 5, 2015.